EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of 3‐(4‐Chlorophenyl)‐4‐(2‐Hydroxyphenyl) 1,3‐Oxazetidin‐2‐One in STZ‐Induced Diabetic Neuropathic Pain in Rats

Manpreet Kaur, Dhruva Kumar, Navjeet Kaur, A M Muthuraman, Sushma Devi iD, Saurabh Gupta iD

Fundamental & Clinical Pharmacology · 2025

DOI: 10.1111/fcp.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2025. Verfasst von Manpreet Kaur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Mata Gujri College, Fatehgarh Sahib, Punjab, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Neuropathies, Neuralgia, Azetidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study was designed to investigate the therapeutic potential of oxazetidin‐2‐one derivatives in a rat model of streptozotocin (STZ)‐induced diabetic neuropathic pain. A single dose of STZ (i.e., 75 mg/kg; i.p.) was administered to induce diabetes‐associated neuropathic pain in rats. The serum glucose level was estimated on days 0, 3, 42, and 45. A battery of behavioral tests, i.e., hot plate, plantar, tail immersion, and tail flick tests, were performed to assess the degree of thermal hyperalgesia in the paw and tail regions at different time intervals, i.e., 42nd and 44th day. Total protein, thiobarbituric acid reactive substances (TBARS), nitrite, reduced glutathione (GSH), and total calcium levels in sciatic nerve tissue were also estimated on the 45th day of the experiment. The test compound (CHO; 5, 10, or 15 mg/kg; p.o.) and pregabalin (10 mg/kg; p.o.) were administered for three consecutive days beginning on the 42nd day after STZ administration. STZ significantly induced diabetic neuropathic pain, as indicated by thermal hyperalgesia in the paw and tail along with increases in the TBARS, nitrite, and total calcium levels and a decrease in the GSH level. Administration of CHO attenuated STZ‐induced behavioral and biochemical changes in a dose‐dependent manner compared to those in the pregabalin‐treated group. The attenuating effect of CHO (15 mg/kg) on STZ‐induced diabetic neuropathic pain may be attributed to its neuroprotective potential via multiple pharmacological actions, including anti‐lipid peroxidation, free radical scavenging, and inhibition of intracellular calcium accumulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic NeuropathiesNeuralgiaAzetidinesAnalgesicsAnimalsMaleRatsStreptozocinRats, WistarPregabalinHyperalgesiaThiobarbituric Acid Reactive SubstancesDose-Response Relationship, DrugCalciumGlutathioneBlood GlucosePain MeasurementSciatic Nerve

Stichwörter der Autor:innen

neuropathic painpregabalinreduced glutathionestreptozotocintotal calcium

Substanzen

StreptozocinPregabalinAzetidinesAnalgesicsThiobarbituric Acid Reactive SubstancesCalciumGlutathioneBlood Glucose

Autor:innen und Institutionen

  • Department of Chemistry, Mata Gujri College, Fatehgarh Sahib, Punjab, India.
  • Department of Chemistry, Guru Nanak College, Budhlada, Punjab, India.
  • Department of Physics, Mata Gujri College, Fatehgarh Sahib, Punjab, India.
  • Department of Pharmacology, Akal Toxicology Research Centre, Akal College of Pharmacy & Technical Education, Sangrur, Punjab, India.
  • Toxicology and Basic Health Sciences Unit, Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia.
  • Chitkara College of Pharmacy, Chitkara University, Rajpura.

ORCID-Profile: Sushma Devi, Saurabh Gupta

Zitieren

APA

Kaur, M., Kumar, D., Kaur, N., Muthuraman, A. M., Devi, S., & Gupta, S. (2025). Therapeutic Potential of 3‐(4‐Chlorophenyl)‐4‐(2‐Hydroxyphenyl) 1,3‐Oxazetidin‐2‐One in STZ‐Induced Diabetic Neuropathic Pain in Rats. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70026

Vancouver

Kaur M, Kumar D, Kaur N, Muthuraman AM, Devi S, Gupta S. Therapeutic Potential of 3‐(4‐Chlorophenyl)‐4‐(2‐Hydroxyphenyl) 1,3‐Oxazetidin‐2‐One in STZ‐Induced Diabetic Neuropathic Pain in Rats. Fundamental & Clinical Pharmacology. 2025. doi:10.1111/fcp.70026

BibTeX
@article{Kaur2025,
  author = {Kaur, Manpreet and Kumar, Dhruva and Kaur, Navjeet and Muthuraman, A M and Devi, Sushma and Gupta, Saurabh},
  title = {Therapeutic Potential of 3‐(4‐Chlorophenyl)‐4‐(2‐Hydroxyphenyl) 1,3‐Oxazetidin‐2‐One in STZ‐Induced Diabetic Neuropathic Pain in Rats},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2025},
  doi = {10.1111/fcp.70026}
}
Kostenlos starten →